Monday, 16 November 2026 X LinkedIn Bluesky RSS Send us news
LungDaily The Pulse of Respiratory Health
World COPD Day is on Wednesday 18 November · #WorldCOPDDay Our coverage →
New Paper Alert

Study assesses performance of biomarkers in diagnosing asthma, combining systematic review and validation cohort

NEJM Clinician highlighted a study that evaluated asthma biomarkers using a systematic review alongside a parallel prospective validation cohort.

“To assess the performance of biomarkers in the diagnosis of asthma, investigators conducted a systematic review and parallel prospective validation cohort.”— NEJM Clinician

NEJM Clinician, a digital resource that describes itself as delivering contextualised insights on impactful research in medicine, highlighted a study on asthma diagnosis in a post on X.

According to the post, investigators set out to assess the performance of biomarkers in the diagnosis of asthma. They conducted a systematic review and a parallel prospective validation cohort.

The post did not name the journal, and it did not report the biomarkers studied, the size of the cohort or the results. It directed readers to a linked page for the key results.

Original source

#asthma#diagnostics

Related stories

More in New Paper Alert

See all

LungDaily reports on public posts, papers and news from the lung health community. This article is based on the source linked above and was produced with AI-assisted tools under our editorial standards; facts and quotes are checked against the original before publication. Featured here, or spotted an error? Request a correction or removal.